Trial Profile
Randomized, Single Blind, Cross-over Study to Evaluate the Palatability of New Orally Disintegrating Tablets of PZQ and L-PZQ Versus Current PZQ Tablets in African Children Age 6-11 Years
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Dec 2018
Price :
$35
*
At a glance
- Drugs Praziquantel (Primary)
- Indications Schistosomiasis
- Focus Therapeutic Use
- Sponsors Merck KGaA
- 11 Jun 2015 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 11 Jun 2015 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 16 Dec 2014 New trial record